<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>There’s a new type of flu vaccine for older adults this year. Can you get it? — Live Feed</title><link>https://www.live-feeds.com/feed/there-s-a-new-type-of-flu-vaccine-for-older-adults-this-year-can-you-get-it</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/there-s-a-new-type-of-flu-vaccine-for-older-adults-this-year-can-you-get-it/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Updated flu vaccines available as 2026 season begins</title><link>https://www.live-feeds.com/feed/there-s-a-new-type-of-flu-vaccine-for-older-adults-this-year-can-you-get-it</link><guid isPermaLink="false">https://www.live-feeds.com/feed/there-s-a-new-type-of-flu-vaccine-for-older-adults-this-year-can-you-get-it#u49969</guid><pubDate>Thu, 27 Aug 2026 11:25:29 +0000</pubDate><description>Updated flu vaccines are now available at pharmacies and clinics. This coincides with the FDA approval of Moderna&amp;#039;s mRNA-based flu vaccine for adults aged 50 years and older. While the general flu shot is accessible, the latest COVID-19 vaccines are not yet available. Patients should consult healthcare providers to determine if the mRNA option is available for their specific demographic as the 2026 to 2027 season starts.Why it mattersThe introduction of mRNA technology for seasonal influenza represents a shift in how older populations are protected from the virus. August is National Immun</description></item>
<item><title>FDA approves Moderna mRNA flu vaccine for adults 50 and older</title><link>https://www.live-feeds.com/feed/there-s-a-new-type-of-flu-vaccine-for-older-adults-this-year-can-you-get-it</link><guid isPermaLink="false">https://www.live-feeds.com/feed/there-s-a-new-type-of-flu-vaccine-for-older-adults-this-year-can-you-get-it#u47141</guid><pubDate>Mon, 24 Aug 2026 04:04:16 +0000</pubDate><description>The FDA approved Moderna&amp;#039;s mRNA-based flu vaccine for adults aged 50 years and older. The company expects the vaccine to be available in the United States for the 2026 to 2027 flu season. This marks a shift toward using messenger RNA technology for seasonal influenza prevention in older populations. Patients should check with healthcare providers regarding specific availability as the 2026 to 2027 season approaches.Why it mattersTraditional flu vaccines often vary in effectiveness for older adults. mRNA technology allows for potentially faster production and precise targeting of viral str</description></item>
</channel></rss>